<p>Dr. Freire sits down with Dr. Mikael Dolsten, Chief Scientific Officer and President of Worldwide Research, Development and Medical of Pfizer, Inc. They explore the approach to and challenges associated with developing the Pfizer-BioNtech COVID 19 vaccine, research efforts on potential treatments and promising new therapeutics for the future. </p>

Dr. Freire sits down with Dr. Mikael Dolsten, Chief Scientific Officer and President of Worldwide Research, Development and Medical of Pfizer, Inc. They explore the approach to and challenges associated with developing the Pfizer-BioNtech COVID 19 vaccine, research efforts on potential treatments and promising new therapeutics for the future.

<p>Dr. Freire sits down with Dr. Mikael Dolsten, Chief Scientific Officer and President of Worldwide Research, Development and Medical of Pfizer, Inc. They explore the approach to and challenges associated with developing the Pfizer-BioNtech COVID 19 vaccine, research efforts on potential treatments and promising new therapeutics for the future.&nbsp;</p>

Interview with Dr. Mikael Dolsten, Pfizer

The podcast featured Dr. Maria Freire, past President and Executive Director of the FNIH interviewing researchers and partners working tirelessly to defeat the COVID-19 pandemic. Guests shared their unique perspective on solutions to this deadly virus.

Share Interview with Dr. Mikael Dolsten, Pfizer

Sign up to save your podcasts

Interview with Dr. Mikael Dolsten, Pfizer

Interview with Dr. Mikael Dolsten, Pfizer